Seer (SEER) Shares Outstanding (2020 - 2026)
Seer (SEER) posted quarterly Shares Outstanding (Entity) of $55.1 million for Q1 2026, down 7.34% year-over-year from $59.4 million in Q1 2025, and down 2.05% quarter-over-quarter from $56.2 million in Q4 2025.
Seer (SEER) Shares Outstanding (2020 - 2026) Analysis & Trends
Seer's Shares Outstanding (Entity) history runs 7 years deep, the most recent figure standing at $55.1 million for Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) fell 7.34% year-over-year to $55.1 million; the TTM figure through Mar 2026 stood at $55.1 million (down 7.34% YoY), while the FY2025 annual figure was $56.2 million, down 4.92% from the prior year.
- Shares Outstanding (Entity) for Q1 2026 stood at $55.1 million, down from $56.2 million in the prior quarter.
- The five-year high for Shares Outstanding (Entity) was $64.9 million in Q1 2024, with the low at $55.1 million in Q1 2026.
- The 5-year median for Shares Outstanding (Entity) is $62.6 million (2022), against an average of $61.0 million.
- The sharpest annual moves came in 2023 and 2025: Shares Outstanding (Entity) climbed 2.32% in 2023, then fell 10.91% in 2025.
- Seer's Shares Outstanding (Entity) stood at $63.4 million in 2022, then climbed by 1.4% to $64.3 million in 2023, then retreated by 8.04% to $59.1 million in 2024, then declined by 4.92% to $56.2 million in 2025, then slipped by 2.05% to $55.1 million in 2026.
- Business Quant data shows SEER's Shares Outstanding (Entity) at $55.1 million in Q1 2026, $56.2 million in Q4 2025, and $55.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 62.19 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 210.89 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.45 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 25.05 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 445.06 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 133.61 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 217.35 Mn |
| 10 | Seer | 230.63 Mn | 230.63 Mn | 1.51 Mn | 55.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 55.16 Mn |
| Mar 31, 2026 | 56.00 Mn |
| Dec 31, 2025 | 57.45 Mn |
| Sep 30, 2025 | 56.31 Mn |
| Jun 30, 2025 | 58.09 Mn |
| Mar 31, 2025 | 59.41 Mn |
| Dec 31, 2024 | 62.35 Mn |
| Sep 30, 2024 | 61.19 Mn |
| Jun 30, 2024 | 64.58 Mn |
| Mar 31, 2024 | 64.59 Mn |
| Dec 31, 2023 | 63.85 Mn |
| Sep 30, 2023 | 63.93 Mn |
| Jun 30, 2023 | 63.76 Mn |
| Mar 31, 2023 | 63.54 Mn |
| Dec 31, 2022 | 62.43 Mn |
| Sep 30, 2022 | 62.54 Mn |
| Jun 30, 2022 | 62.38 Mn |
| Mar 31, 2022 | 62.00 Mn |
| Dec 31, 2021 | 60.86 Mn |
| Sep 30, 2021 | 61.13 Mn |